DFTX compared with TLRY: revenue, margins and what each company keeps, and the suppliers and customers both name

DFTXDefinium Therapeutics, Inc.

Mkt capRevenueRevenue

TLRYTilray Brands, Inc.

Mkt capRevenueRevenue

Compare

DFTXDefinium Therapeutics, Inc.

TLRYTilray Brands, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

DFTX: latest quarter not drawable. TLRY: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: DFTX, TLRY.

Role chip = supplier or customerSource: SEC EDGAR

DFTXDefinium Therapeutics, Inc.

33.36· pre 33.75· delayed

Mkt cap$4.4BRevenue—Revenue—

TLRYTilray Brands, Inc.

2.65· pre 2.77· delayed

Pre-marketNov 4 '26delayed

Mkt cap$391.6MRevenue$257MQ1 FY27Revenue$915MFY26

Compare

Pre-marketNov 4 '26delayed

DFTXDefinium Therapeutics, Inc.

TLRYTilray Brands, Inc.

33.36pre 33.75delayed

Price

2.65pre 2.77delayed

$4.4B

Mkt cap

$391.6M

—

Revenue

$257MQ1 FY27

—

Revenue

$915MFY26

DFTX33.36vsTLRY2.65Pre-marketNov 4 '26delayed

Price

rebased to 0%

DFTX, solidTLRY, dashed